Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth

Life Sci
12 November 1984
https://pubmed.ncbi.nlm.nih.gov/6092812/

Naltrexone modulates growth in infant rats

Life Sci
12 December 1983
https://pubmed.ncbi.nlm.nih.gov/6316064/

Featured Article: Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone

Exp Biol Med (Maywood)
September 2017
https://pubmed.ncbi.nlm.nih.gov/28766982/

The Use of Naltrexone in Low Doses Beyond the Approved Indication [Internet]

Report from Norwegian Knowledge Centre for the Health Services
April 2015
https://pubmed.ncbi.nlm.nih.gov/28510411/

Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis

Exp Biol Med (Maywood)
February 2018
https://pubmed.ncbi.nlm.nih.gov/29307283/

McLaughlin leads research on identifying minimally invasive biomarkers for MS

Penn State News
10 April 2018
https://news.psu.edu/story/515260/2018/04/10/research/mclaughlin-leads-research-identifying-minimally-invasive-biomarkers

Low-dose Naltrexone Changes Levels of Inflammatory Proteins in MS, Study Shows

MS News Today
20 February 2018
https://multiplesclerosisnewstoday.com/2018/02/20/low-dose-naltrexone-changes-levels-inflammatory-proteins-in-ms/

Morphine reduced perceived anger from neutral and implicit emotional expressions

Psychoneuroendocrinology
May 2018
https://pubmed.ncbi.nlm.nih.gov/29550675/

Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers

Eur J Pharm Sci
15 September 2018
https://pubmed.ncbi.nlm.nih.gov/29940217/

Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care

Cochrane Database Syst Rev
05 June 2018
https://www.ncbi.nlm.nih.gov/pubmed/29869799